Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjolein de Bruin-Weller

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
The British Journal of Dermatology|April 25, 2024
The pleiotropic role of interleukin-13 in the pathogenesis of atopic dermatitisCoco Dekkers, Marjolein de Bruin-Weller
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2019
ReplyAndreas Wollenberg, Stephan Thurau, Marjolein de Bruin-Weller
Acta Dermato-Venereologica|January 9, 2025
Exploring Social Health in Patients with Atopic Dermatitis: An Observational, Cross-sectional, Questionnaire Based Study on Social Participation and Emotional SupportEsmé Kamphuis, Laura Loman, Marjolein De Bruin-Weller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 16, 2019
Management of dupilumab-associated conjunctivitis in atopic dermatitisNora Aszodi, Stephan Thurau, Marlene Seegräber, et al.
Chemical Immunology and Allergy|March 22, 2012
Bone mineral density in patients with atopic dermatitisInge Haeck, Sara van Velsen, Marjolein de Bruin-Weller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2019
Management der Dupilumab-assoziierten Konjunktivitis beim atopischen EkzemNora Aszodi, Stephan Thurau, Marlene Seegräber, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 30, 2007
Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patientsDirk Jan Hijnen, Edward Knol, Carla Bruijnzeel-Koomen, et al.
Journal of the American Academy of Dermatology|August 31, 2025
Response to Bissonnette et al. 'Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, phase 4 clinical study (BALISTAD)'Julia Clabbers, Celeste Boesjes, Michel van Geel, et al.
The Journal of Allergy and Clinical Immunology|February 15, 2023
Biomarkers in atopic dermatitisDaphne Bakker, Marjolein de Bruin-Weller, Julia Drylewicz, et al.
Journal of Clinical Medicine|August 5, 2015
Sick Leave and Factors Influencing Sick Leave in Adult Patients with Atopic Dermatitis: A Cross-Sectional StudyHarmieke van Os-Medendorp, Simone Appelman-Noordermeer, Carla Bruijnzeel-Koomen, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
The British Journal of Dermatology|April 25, 2024
The pleiotropic role of interleukin-13 in the pathogenesis of atopic dermatitisCoco Dekkers, Marjolein de Bruin-Weller
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2019
ReplyAndreas Wollenberg, Stephan Thurau, Marjolein de Bruin-Weller
Acta Dermato-Venereologica|January 9, 2025
Exploring Social Health in Patients with Atopic Dermatitis: An Observational, Cross-sectional, Questionnaire Based Study on Social Participation and Emotional SupportEsmé Kamphuis, Laura Loman, Marjolein De Bruin-Weller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 16, 2019
Management of dupilumab-associated conjunctivitis in atopic dermatitisNora Aszodi, Stephan Thurau, Marlene Seegräber, et al.
Chemical Immunology and Allergy|March 22, 2012
Bone mineral density in patients with atopic dermatitisInge Haeck, Sara van Velsen, Marjolein de Bruin-Weller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2019
Management der Dupilumab-assoziierten Konjunktivitis beim atopischen EkzemNora Aszodi, Stephan Thurau, Marlene Seegräber, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 30, 2007
Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patientsDirk Jan Hijnen, Edward Knol, Carla Bruijnzeel-Koomen, et al.
Journal of the American Academy of Dermatology|August 31, 2025
Response to Bissonnette et al. 'Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, phase 4 clinical study (BALISTAD)'Julia Clabbers, Celeste Boesjes, Michel van Geel, et al.
The Journal of Allergy and Clinical Immunology|February 15, 2023
Biomarkers in atopic dermatitisDaphne Bakker, Marjolein de Bruin-Weller, Julia Drylewicz, et al.
Journal of Clinical Medicine|August 5, 2015
Sick Leave and Factors Influencing Sick Leave in Adult Patients with Atopic Dermatitis: A Cross-Sectional StudyHarmieke van Os-Medendorp, Simone Appelman-Noordermeer, Carla Bruijnzeel-Koomen, et al.
Pageof 10